Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Cell Immunol ; 280(1): 1-9, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23246829

RESUMEN

Vitamin-D3 upregulated protein-1 (VDUP1) is a stress response protein. Pseudomonas aeruginosa (P. aeruginosa) infection is a leading cause of death. Mice infected with live P. aeruginosa exhibit significantly decreased VDUP1 expression. However, the function of VDUP1 during P. aeruginosa-induced mouse bacteremic shock is unknown. To address the function of VDUP1 in P. aeruginosa-infected mice, we constructed a bacteremic shock model wherein both wild-type and VDUP1-deficient mice were infected intra-peritoneally with live P. aeruginosa. We found that VDUP1-deficient mice were more resistant to P. aeruginosa-induced bacteremic shock than wild-type mice, as shown by the increased survival, accelerated bacterial clearance and suppression of cytokine overproduction of the VDUP1-deficient mice. VDUP1 promoted the recruitment of neutrophils into the peritoneal cavities of infected mice. VDUP1 impeded the phagocytosis of non-opsonized P. aeruginosa via phosphatidylinositide 3-kinase (PI3K) pathway in macrophages. P. aeruginosa infection induced the generation of reactive oxygen species (ROS), and the increased production of ROS by the peritoneal cells of VDUP1-deficient mice was advantageous in clearing the bacteria. Overall, VDUP1 aggravates bacteremic shock; thus, VDUP1 can be considered a target molecule for the inhibition of P. aeruginosa-induced bacteremic shock.


Asunto(s)
Proteínas Portadoras/fisiología , Peritonitis/fisiopatología , Infecciones por Pseudomonas/fisiopatología , Choque Séptico/fisiopatología , Tiorredoxinas/fisiología , Animales , Apoptosis/fisiología , Proteínas Portadoras/genética , Quimiotaxis de Leucocito/fisiología , Recuento de Colonia Microbiana , Citocinas/biosíntesis , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Neutrófilos/patología , Cavidad Peritoneal/microbiología , Cavidad Peritoneal/patología , Peritonitis/microbiología , Fagocitosis/fisiología , Fosfatidilinositol 3-Quinasas/fisiología , Pseudomonas aeruginosa/crecimiento & desarrollo , Pseudomonas aeruginosa/aislamiento & purificación , Especies Reactivas de Oxígeno/metabolismo , Transducción de Señal/fisiología , Organismos Libres de Patógenos Específicos , Bazo/microbiología , Tiorredoxinas/genética
2.
J Immunol ; 185(2): 917-28, 2010 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-20543098

RESUMEN

NK cells are capable of killing virus-infected or tumor cells and producing IFN-gamma. Resting NK cells, however, have only minimal cytolytic activity and secrete a low level of IFN-gamma. The cytokine IL-15 can promote the expression of effector functions by resting NK cells. In this study, we demonstrate that suppressor of cytokine signaling 2 (SOCS2) has a novel role in IL-15-primed human NK cell function. SOCS2 expression was upregulated in NK cells following stimulation with IL-15. During IL-15-mediated NK cell priming, SOCS2 interacted with phosphorylated proline-rich tyrosine kinase 2 (Pyk2) at tyrosine 402 (p-Pyk2(Tyr402)) and induced the proteasome-mediated degradation of p-Pyk2(Tyr402) via ubiquitination. Knockdown of SOCS2 resulted in the accumulation of p-Pyk2(Tyr402) and blocked NK cell effector functions. In addition, NK cell cytolytic activity and IFN-gamma production were inhibited by overexpression of the wild-type of Pyk2 but not by the overexpression of tyrosine 402 mutant of Pyk2. These results suggest that SOCS2 regulates human NK cell effector functions via control of phosphorylated Pyk2 depending on IL-15 existence.


Asunto(s)
Quinasa 2 de Adhesión Focal/metabolismo , Interleucina-15/farmacología , Células Asesinas Naturales/efectos de los fármacos , Proteínas Supresoras de la Señalización de Citocinas/metabolismo , Western Blotting , Diferenciación Celular/efectos de los fármacos , Línea Celular , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Citotoxicidad Inmunológica/efectos de los fármacos , Citotoxicidad Inmunológica/inmunología , Quinasa 2 de Adhesión Focal/genética , Humanos , Recién Nacido , Interferón gamma/metabolismo , Células Jurkat , Células K562 , Células Asesinas Naturales/inmunología , Células Asesinas Naturales/metabolismo , Mutación , Fosforilación/efectos de los fármacos , Unión Proteica , Interferencia de ARN , Receptores de Interleucina-15/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal/efectos de los fármacos , Proteínas Supresoras de la Señalización de Citocinas/genética , Tirosina/metabolismo
3.
PLoS Pathog ; 5(8): e1000561, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19714221

RESUMEN

Pseudomonas aeruginosa (PA) is an opportunistic pathogen that causes the relapse of illness in immunocompromised patients, leading to prolonged hospitalization, increased medical expense, and death. In this report, we show that PA invades natural killer (NK) cells and induces phagocytosis-induced cell death (PICD) of lymphocytes. In vivo tumor metastasis was augmented by PA infection, with a significant reduction in NK cell number. Adoptive transfer of NK cells mitigated PA-induced metastasis. Internalization of PA into NK cells was observed by transmission electron microscopy. In addition, PA invaded NK cells via phosphoinositide 3-kinase (PI3K) activation, and the phagocytic event led to caspase 9-dependent apoptosis of NK cells. PA-mediated NK cell apoptosis was dependent on activation of mitogen-activated protein (MAP) kinase and the generation of reactive oxygen species (ROS). These data suggest that the phagocytosis of PA by NK cells is a critical event that affects the relapse of diseases in immunocompromised patients, such as those with cancer, and provides important insights into the interactions between PA and NK cells.


Asunto(s)
Apoptosis/inmunología , Células Asesinas Naturales/inmunología , Fagocitosis/inmunología , Pseudomonas aeruginosa/inmunología , Animales , Caspasa 9/inmunología , Caspasa 9/metabolismo , Línea Celular Tumoral , Supervivencia Celular/fisiología , Citometría de Flujo , Humanos , Inmunohistoquímica , Células Asesinas Naturales/metabolismo , Células Asesinas Naturales/microbiología , Melanoma/inmunología , Melanoma/microbiología , Ratones , Ratones Endogámicos C57BL , Microscopía Electrónica de Transmisión , Metástasis de la Neoplasia , Trasplante de Neoplasias , Fosfatidilinositol 3-Quinasas/metabolismo , Especies Reactivas de Oxígeno/metabolismo
4.
J Immunol ; 183(12): 7931-8, 2009 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-19933860

RESUMEN

Cross-linking of NK activating receptors activates phospholipase-gamma and subsequently induces diacylglycerol and Ca(2+) as second messengers of signal transduction. Previous studies reported that Ras guanyl nucleotide-releasing protein (RasGRP) 1, which is activated by diacylglycerol and Ca(2+), is crucial for TCR-mediated Ras-ERK activation. We now report that RasGRP1, which can also be detected in human NK cells, plays an essential role in NK cell effector functions. To examine the role of RasGRP1 in NK cell functions, the expression of RasGRP1 was suppressed using RNA interference. Knockdown of RasGRP1 significantly blocked ITAM-dependent cytokine production as well as NK cytotoxicity. Biochemically, RasGRP1-knockdown NK cells showed markedly decreased ability to activate Ras, ERK, and JNK. Activation of the Ras-MAPK pathway was independently shown to be indispensable for NK cell effector functions via the use of specific pharmacological inhibitors. Our results reveal that RasGRP1 is required for the activation of the Ras-MAPK pathway leading to NK cell effector functions. Moreover, our data suggest that RasGRP1 might act as an important bridge between phospholipase-gamma activation and NK cell effector functions via the Ras-MAPK pathway.


Asunto(s)
Proteínas de Unión al ADN/fisiología , Factores de Intercambio de Guanina Nucleótido/fisiología , Células Asesinas Naturales/inmunología , Células Asesinas Naturales/metabolismo , Línea Celular Tumoral , Proteínas de Unión al ADN/deficiencia , Proteínas de Unión al ADN/genética , Sangre Fetal/citología , Sangre Fetal/inmunología , Sangre Fetal/metabolismo , Factores de Intercambio de Guanina Nucleótido/deficiencia , Factores de Intercambio de Guanina Nucleótido/genética , Humanos , Líquido Intracelular/inmunología , Líquido Intracelular/metabolismo , Células K562 , Células Asesinas Naturales/patología , Transducción de Señal/genética , Transducción de Señal/inmunología , Cordón Umbilical/irrigación sanguínea , Cordón Umbilical/citología , Cordón Umbilical/inmunología
5.
J Immunol ; 183(4): 2495-505, 2009 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-19625652

RESUMEN

Hematopoietic stem cells (HSCs) are maintained in a quiescent state in bone marrow (BM) niches by intrinsic and extrinsic signals. The mechanisms regulating the quiescence and mobilization of HSCs, however, remain unclear. In this study, we report that the expression of thioredoxin-interacting protein (TXNIP) is decreased during HSC activation. In Txnip(-/-) mice, the long-term reconstituting HSC population is decreased and exhausted, and its capacity to repopulate is rapidly lost. These effects are associated with hyperactive Wnt signaling, an active cell cycle, and reduced p21 expression under conditions of stress. TXNIP deficiency reduced the CXCL12- and osteopontin-mediated interaction between HSCs and the bone marrow, and impaired homing and retention in the osteoblastic niche, resulting in mobilized HSCs. Therefore, we propose that TXNIP is essential for maintaining HSC quiescence and the interaction between HSCs and the BM niche.


Asunto(s)
Proteínas Portadoras/fisiología , Movimiento Celular/fisiología , Células Madre Hematopoyéticas/fisiología , Fase de Descanso del Ciclo Celular/fisiología , Estrés Fisiológico , Tiorredoxinas/fisiología , Animales , Células de la Médula Ósea/citología , Células de la Médula Ósea/metabolismo , Células de la Médula Ósea/fisiología , Proteínas Portadoras/genética , Movimiento Celular/genética , Células Cultivadas , Células Madre Hematopoyéticas/citología , Células Madre Hematopoyéticas/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Fase de Descanso del Ciclo Celular/genética , Transducción de Señal/genética , Estrés Fisiológico/genética , Tiorredoxinas/genética , Factores de Tiempo , Proteína Wnt1/antagonistas & inhibidores , Proteína Wnt1/fisiología
6.
Stem Cells ; 26(8): 2114-23, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18535152

RESUMEN

The detailed mechanisms driving the development of natural killer (NK) cells from hematopoietic stem cells remain to be clearly elucidated. Here, we show that osteopontin (OPN) is a key factor for NK development. OPN-deficient mice evidenced severe impairments of NK development in bone marrow (BM) and spleen in which the NK populations that express CD122 and NK cell receptors were reduced. However, the absence of intrinsic OPN expression did not affect NK development, whereas the absence of OPN in the microenvironment caused a significant reduction in NK population. The expression of OPN was induced by interleukin (IL)-15 in BM stromal cells, and the defect in NK differentiation in IL-15(-/-) hematopoietic precursor cells (HPC) was recovered by addition of recombinant OPN, suggesting that the microenvironmental OPN may be a key factor in IL-15-mediated NK differentiation. In addition, OPN-driven NK maturation was reduced in T-bet-deficient HPC, suggesting that T-bet is required for OPN-mediated NK development. Collectively, these results show that paracrine OPN signaling drives NK-lineage commitment, thus ultimately promoting NK cell development. Disclosure of potential conflicts of interest is found at the end of this article.


Asunto(s)
Regulación de la Expresión Génica , Células Madre Hematopoyéticas/citología , Interleucina-15/biosíntesis , Células Asesinas Naturales/citología , Osteopontina/metabolismo , Proteínas de Dominio T Box/metabolismo , Animales , Células de la Médula Ósea/citología , Diferenciación Celular , Interleucina-15/metabolismo , Subunidad beta del Receptor de Interleucina-2/biosíntesis , Células Asesinas Naturales/metabolismo , Ratones , Ratones Endogámicos C57BL , Modelos Biológicos , Osteopontina/química , Proteínas Recombinantes/química , Bazo/metabolismo
7.
Chin J Nat Med ; 15(4): 281-287, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28527513

RESUMEN

The present study was designed to perform structural modifications of of neobavaisoflavone (NBIF), using an in vitro enzymatic glycosylation reaction, in order to improve its water-solubility. Two novel glucosides of NBIF were obtained from an enzymatic glycosylation by UDP-glycosyltransferase. The glycosylated products were elucidated by LC-MS, HR-ESI-MS, and NMR analysis. The HPLC peaks were integrated and the concentrations in sample solutions were calculated. The MTT assay was used to detect the cytotoxic activity of compounds in cancer cell lines. Based on the spectroscopic analyses, the two novel glucosides were identified as neobavaisoflavone-4'-O-ß-D-glucopyranoside (1) and neobavaisoflavone-4', 7-di-O-ß-D-glucopyranoside (2). Additionally, the water-solubilities of compounds 1 and 2 were approximately 175.1- and 4 031.9-fold higher than that of the substrate, respectively. Among the test compounds, only NBIF exhibited weak cytotoxicity against four human cancer cell lines, with IC50 values ranging from 63.47 to 72.81 µmol·L-1. These results suggest that in vitro enzymatic glycosylation is a powerful approach to structural modification, improving water-solubility.


Asunto(s)
Glucósidos/biosíntesis , Glicosiltransferasas/metabolismo , Isoflavonas/biosíntesis , Antineoplásicos/metabolismo , Antineoplásicos/farmacología , Bacillus/enzimología , Línea Celular Tumoral , Colorimetría , Ensayos de Selección de Medicamentos Antitumorales , Glucósidos/química , Humanos , Isoflavonas/química , Estructura Molecular , Solubilidad
8.
Mol Cells ; 34(6): 555-61, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23161172

RESUMEN

Olfactomedin 4 (OLFM4) is highly expressed in gastrointestinal cancers and has an anti-apoptotic function. The roles of OLFM4 in tumor growth and metastasis and how it functions in these processes remain elusive. We investigated the function of OLFM4 in tumor growth and metastasis using B16F10 mouse melanoma cells as an experimental system. Our results showed that OLFM4 had no positive effect on cell viability or cell cycle progression in B16F10 cells. However, it significantly suppressed the tumorigenicity of B16F10 cells, i.e., intradermal primary tumor growth and lung metastasis. OLFM4 also suppressed the migration and invasion of B16F10 cells in vitro. For further insight into the mechanisms underlying OLFM4-mediated suppression of tumor progression, we examined the effect of OLFM4 on the expression of integrin and matrix metalloproteinase (MMP), both of which are involved in tumor progression. Overexpression of OLFM4 clearly reduced the expression levels of integrin α1, integrin α4, integrin α5, integrin α6, and MMP9. Moreover, forced expression of MMP9 attenuated the inhibitory activity of OLFM4 on migration and invasiveness. Our findings provide the experimental evidence that OLFM4 may function as a tumor suppressor and an anti-metastatic gene during tumor progression.


Asunto(s)
Regulación hacia Abajo , Proteínas de la Matriz Extracelular/metabolismo , Glicoproteínas/metabolismo , Integrinas/genética , Metaloproteinasa 9 de la Matriz/genética , Melanoma Experimental/metabolismo , Animales , Supervivencia Celular , Humanos , Integrina alfa1/genética , Integrina alfa1/metabolismo , Integrina alfa6/genética , Integrina alfa6/metabolismo , Integrinas/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Melanoma Experimental/patología , Ratones , Ratones Endogámicos C57BL , Metástasis de la Neoplasia , Células Tumorales Cultivadas
9.
Immunol Lett ; 136(1): 29-36, 2011 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-21126536

RESUMEN

Natural killer (NK) cells act important roles in innate immunity and adaptive immunity. However, the mechanisms governing NK cell development have not been clearly elucidated. Previous studies have shown that an HMG (high-mobility group) protein, TOX, is important for regulating the differentiation program of developing T cells in mice. In this study, we examined the role of TOX in differentiation of human NK cells. Knockdown of TOX in differentiating cells decreased the NK cell population identified by expression of NK surface markers and receptors. In addition, over-expression of TOX enhanced the differentiation of NK cells which give rise to a population showing effector functions of mature NK cells. Moreover, TOX influenced expression of T-bet (T-box expressed in T cells, also as known as Tbx21) during NK cell development. Overall, these results suggest that TOX is required for IL-15-mediated NK cell differentiation and affected expression of T-bet that plays critical roles in NK differentiation and maturation.


Asunto(s)
Diferenciación Celular , Células Madre Hematopoyéticas/inmunología , Proteínas del Grupo de Alta Movilidad/inmunología , Células Asesinas Naturales/citología , Células Asesinas Naturales/inmunología , Regulación de la Expresión Génica , Células Madre Hematopoyéticas/citología , Proteínas del Grupo de Alta Movilidad/genética , Humanos , Células K562 , ARN Interferente Pequeño/genética , Transcripción Genética
10.
Immunol Lett ; 141(1): 61-7, 2011 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-21835206

RESUMEN

The IL-22 NKp46(+) innate lymphoid cells, NCR22 cells, are very important for the early host defense against microbial pathogens. We show here that NCR22 cells were differentiated from Lin(-)CD127(+)CD117(+) cells that were derived from hematopoietic precursor cells (HPCs) of mouse bone marrow cells. The combination of low concentrations of IL-23 and IL-15 induced differentiation of NCR22 cells from Lin(-)CD127(+)CD117(+) cells. NCR22 cells expressed a large amount of IL-22 and RORγt, and they had poor cytolytic activity and produced little IFN-γ. Lin(-)CD127(+)CD117(+) cells were very similar to intestinal lamina propria LTi-like cells; both cells dominantly expressed RORγt and IL-22. Meanwhile, Lin(-)CD127(-)CD117(+) cells that were also derived from HPCs did not express RORγt and IL-22, and they developed into conventional NK cells, not into NCR22 cells. These findings revealed that NCR22 cells can be differentiated from Lin(-)CD127(+)CD117(+) cells which are derived from HPCs.


Asunto(s)
Antígenos Ly/metabolismo , Diferenciación Celular/fisiología , Interleucinas/biosíntesis , Células Asesinas Naturales , Receptor 1 Gatillante de la Citotoxidad Natural/metabolismo , Miembro 3 del Grupo F de la Subfamilia 1 de Receptores Nucleares/biosíntesis , Animales , Femenino , Células Madre Hematopoyéticas/metabolismo , Interleucina-15/inmunología , Interleucina-15/metabolismo , Interleucina-23/metabolismo , Subunidad alfa del Receptor de Interleucina-7/metabolismo , Mucosa Intestinal/metabolismo , Células Asesinas Naturales/citología , Células Asesinas Naturales/metabolismo , Linfocitos/metabolismo , Ratones , Ratones Endogámicos , Ratones Noqueados , Proteínas Proto-Oncogénicas c-kit/metabolismo , Interleucina-22
11.
Int Immunopharmacol ; 10(4): 481-6, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20116458

RESUMEN

NK cells play crucial roles in innate immunity and adaptive immunity. The detailed mechanisms, however, governing NK cell development remains unclear. In this study, we report that YC-1 significantly enhances NK cell populations differentiated from human umbilical cord blood hematopoietic stem cells (HSCs). NK cells increased by YC-1 display both phenotypic and functional features of fully mature NK (mNK) cells, but YC-1 does not affect the activation of mNK cells. YC-1 did not affect cGMP production and phosphorylation of STAT-5 which is essential for IL-15R signaling. On the other hand, YC-1 increased p38 MAPK phosphorylation during NK cell differentiation. Furthermore, p38 inhibitor SB203580 inhibited the differentiation of NK cells enhanced by YC-1. Taken together, these data suggest that YC-1 enhances NK cell differentiation through the activation of p38 MAPK which is involved in NK cell differentiation.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Activadores de Enzimas/farmacología , Células Madre Hematopoyéticas/efectos de los fármacos , Indazoles/farmacología , Células Asesinas Naturales/efectos de los fármacos , Western Blotting , Línea Celular Tumoral , GMP Cíclico/metabolismo , Inhibidores Enzimáticos/farmacología , Sangre Fetal/citología , Citometría de Flujo , Humanos , Imidazoles/farmacología , Indazoles/antagonistas & inhibidores , Fosforilación , Piridinas/farmacología , Receptores de Interleucina-15/efectos de los fármacos , Factor de Transcripción STAT5/biosíntesis , Transducción de Señal/efectos de los fármacos , Proteínas Quinasas p38 Activadas por Mitógenos/antagonistas & inhibidores , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
12.
Immunol Lett ; 129(2): 78-84, 2010 Apr 08.
Artículo en Inglés | MEDLINE | ID: mdl-20156484

RESUMEN

The detailed mechanism driving the germinal center (GC) reaction to B cell lymphomagenesis has not been clarified. Thioredoxin interacting protein (TXNIP), also known as vitamin D3 up-regulated protein 1 which is an important tumor repressor, is involved in stress responses, redox regulation, and cellular proliferation. Here, we report that TXNIP has a potential role in the formation of GC in peripheral lymphoid organs where B lymphocytes divide rapidly. First, we compared changes in GC from wild type mice and Txnip(-/-) mice. After immunization, Txnip(-/-) mice exhibited higher expression level of BCL-6 and larger percentage of GC B cells with the reduction in antibody production and plasma cell numbers. In addition, Txnip(-/-) spleens had a much larger population which expressed Ki-67, a marker of cell proliferation, in the red pulp border than WT spleens. Furthermore, the expression of BCL-6 was decreased in TXNIP overexpressing cells and elevated in TXNIP deficient cells. Taken together, we conclude that TXNIP may contribute to the formation of GCs after immunization. During this process, TXNIP suppresses BCL-6 expression.


Asunto(s)
Linfocitos B/inmunología , Proteínas Portadoras/inmunología , Regulación hacia Abajo , Centro Germinal/citología , Centro Germinal/inmunología , Proteínas Proto-Oncogénicas c-bcl-6/inmunología , Animales , Secuencia de Bases , Western Blotting , Proliferación Celular , Citometría de Flujo , Inmunohistoquímica , Masculino , Ratones , Ratones Noqueados , Datos de Secuencia Molecular , Plásmidos/genética , Proteínas Proto-Oncogénicas c-bcl-6/genética
13.
Immunity ; 22(2): 195-208, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15723808

RESUMEN

Vitamin D3 upregulated protein 1 (VDUP1) is a stress-response gene that is upregulated by 1,25(OH)2D3 in tumor cells. The in vivo roles of VDUP1 were investigated by producing mice lacking VDUP1 (VDUP1-/- mice). VDUP1-/- mice showed minimal changes in the development of T and B cells, but there was a profound reduction in the numbers of natural killer (NK) cells. As well, these mice showed decreased NK activity. In the VDUP1-/- mice, the expression of CD122 was reduced, demonstrating that VDUP1 is required for CD122 expression and NK maturation. In addition, severe lymphoid hyperplasia in the small intestine was observed in VDUP1-/- mice. Taken together, these results suggest that VDUP1 is a critical factor for the development and function of NK cells in vivo.


Asunto(s)
Proteínas Portadoras/metabolismo , Diferenciación Celular , Células Asesinas Naturales/inmunología , Células Asesinas Naturales/metabolismo , Tiorredoxinas/metabolismo , Animales , Linfocitos B/citología , Linfocitos B/inmunología , Linfocitos B/metabolismo , Proteínas Portadoras/genética , Proteínas Portadoras/inmunología , Línea Celular , Eliminación de Gen , Regulación de la Expresión Génica , Humanos , Hiperplasia/metabolismo , Hiperplasia/patología , Células Asesinas Naturales/citología , Ratones , Ratones Noqueados , Trasplante de Neoplasias , Neoplasias/inmunología , Neoplasias/metabolismo , Receptores de Interleucina-2/metabolismo , Linfocitos T/citología , Linfocitos T/inmunología , Linfocitos T/metabolismo , Tiorredoxinas/genética , Tiorredoxinas/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA